Cambrium
Biotechnology ResearchBerlin, Germany11-50 Employees
Cambrium is a Berlin-based biotechnology company focused on expanding material science by creating novel molecular building blocks with functionalities beyond those found in conventional molecules. It relies on a platform described as Molecular Intelligence to enable the design and development of materials with new capabilities. In late 2023 it launched NovaColl, the company’s first molecular ingredient, signaling a move toward practical applications. Cambrium serves customers across industries seeking enhanced material performance and novel functional ingredients. A notable recent development is a collaboration with Brenntag Specialties to develop vegan, skin-identical collagen, highlighting interest in personal-care applications. Based in Berlin, the company is a small to mid-sized biotechnology outfit focused on advancing its molecular-building-block approach.
1-888-653-2347 
support@leadiq.com 
